Multifunctional Pt(iv) prodrug candidates featuring the carboplatin core and deferoxamine

Sophia Harringer; Michaela Hejl; Eva A. Enyedy; Michael A. Jakupec; Mathea Sophia Galanski; Bernhard K. Keppler; Paul J. Dyson; Hristo P. Varbanov

doi:10.1039/d1dt00214g

Multifunctional Pt(iv) prodrug candidates featuring the carboplatin core and deferoxamine

Sophia Harringer
, Michaela Hejl
, Eva A. Enyedy
, Michael A. Jakupec
, Mathea Sophia Galanski
, Bernhard K. Keppler
, Paul J. Dyson
, Hristo P. Varbanov (Corresponding author)

Publications: Contribution to journal › Article › Peer Reviewed

Original language	English
Pages (from-to)	8167-8178
Number of pages	12
Journal	Dalton Transactions
Volume	50
Issue number	23
DOIs	https://doi.org/10.1039/d1dt00214g
Publication status	Published - 18 May 2021

Funding

The support of the Austrian Science Fund (FWF, Project number: J3577-B13) and the Ministry of Human Capacities of Hungary (Grant TKP-2020) is gratefully acknowledged.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Austrian Fields of Science 2012

104003 Inorganic chemistry
301904 Cancer research
301206 Pharmacology

Keywords

PLATINUM(IV) PRODRUG
DESFERRIOXAMINE B
TETRACARBOXYLATOPLATINUM(IV) COMPLEXES
DEACETYLASE INHIBITOR
ANTICANCER AGENTS
CISPLATIN
DRUG
LIGANDS
LIPOPHILICITY
DERIVATIVES

Access to Document

10.1039/d1dt00214g

Cite this

@article{cbcc26f62320496ea7c597d0498325b0,

title = "Multifunctional Pt(iv) prodrug candidates featuring the carboplatin core and deferoxamine",

keywords = "PLATINUM(IV) PRODRUG, DESFERRIOXAMINE B, TETRACARBOXYLATOPLATINUM(IV) COMPLEXES, DEACETYLASE INHIBITOR, ANTICANCER AGENTS, CISPLATIN, DRUG, LIGANDS, LIPOPHILICITY, DERIVATIVES",

author = "Sophia Harringer and Michaela Hejl and Enyedy, \{Eva A.\} and Jakupec, \{Michael A.\} and Galanski, \{Mathea Sophia\} and Keppler, \{Bernhard K.\} and Dyson, \{Paul J.\} and Varbanov, \{Hristo P.\}",

note = "Publisher Copyright: {\textcopyright} The Royal Society of Chemistry 2021.",

year = "2021",

month = may,

day = "18",

doi = "10.1039/d1dt00214g",

language = "English",

volume = "50",

pages = "8167--8178",

journal = "Dalton Transactions",

issn = "1477-9226",

publisher = "ROYAL SOC CHEMISTRY",

number = "23",

}

TY - JOUR

T1 - Multifunctional Pt(iv) prodrug candidates featuring the carboplatin core and deferoxamine

AU - Harringer, Sophia

AU - Hejl, Michaela

AU - Enyedy, Eva A.

AU - Jakupec, Michael A.

AU - Galanski, Mathea Sophia

AU - Keppler, Bernhard K.

AU - Dyson, Paul J.

AU - Varbanov, Hristo P.

N1 - Publisher Copyright: © The Royal Society of Chemistry 2021.

PY - 2021/5/18

Y1 - 2021/5/18

KW - PLATINUM(IV) PRODRUG

KW - DESFERRIOXAMINE B

KW - TETRACARBOXYLATOPLATINUM(IV) COMPLEXES

KW - DEACETYLASE INHIBITOR

KW - ANTICANCER AGENTS

KW - CISPLATIN

KW - DRUG

KW - LIGANDS

KW - LIPOPHILICITY

KW - DERIVATIVES

UR - https://www.scopus.com/pages/publications/85108018195

U2 - 10.1039/d1dt00214g

DO - 10.1039/d1dt00214g

M3 - Article

SN - 1477-9226

VL - 50

SP - 8167

EP - 8178

JO - Dalton Transactions

JF - Dalton Transactions

IS - 23

ER -

Multifunctional Pt(iv) prodrug candidates featuring the carboplatin core and deferoxamine

Funding

UN SDGs

Austrian Fields of Science 2012

Keywords

Access to Document

Other files and links

Fingerprint

Cite this